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Background
India has the third largest estimated number of HIV
infected people and 40 million individuals in India are
estimated to be Hepatitis B virus infected. In compari-
son to HBV mono-infection, the course of chronic HBV
infection is more accelerated in HIV/HBV co-infected
subjects. We analyzed the baseline characteristics of the
HIV/HBV co-infected and HIV mono-infected patients.
Methods
Between July 2011 and January 2013, a total number of
1331 HIV-seropositive treatment naïve individuals,
enrolled in the ART Centre of Calcutta School of Tropi-
cal Medicine were screened for HBsAg. A number of
1253 HIV mono-infected and 78 HIV/HBV co-infected
patients were characterized. The co-infected patients
were evaluated for HBeAg and anti HBe antibody by
ELISA. HBV DNA was detected by nested PCR amplifi-
cation followed by HBV genotype determination.
Results
The median age (35 years) was similar in HIV mono-
infected and HIV/HBV co-infected group. The proportion
of advanced HIV disease (WHO clinical stage III & IV) was
more in HIV/HBV co-infected patients (37.1% vs. 19.9%)
than HIV mono-infected subjects. The co-infected subjects
had significantly higher serum bilirubin, ALT, alkaline
phosphatase, creatinine and ALT/platelet ratio index. CD4
count was non significantly lower in co-infected patients.
Majority (61.5%) were HBeAg reactive with higher HBV
DNA (p=0.0001) and APRI (p=0.04) as compared to
HBeAg negative (38.5%) patients. Genotype HBV/D
(71.7%) was the predominant genotype followed by HBV/A
(19.4%) and HBV/C (8.9%) among the co-infected patients
from eastern India.
Conclusion
HIV/HBV co-infection warrants long term prospective
study on immune recovery, HIV and HBV viral replica-
tion, and hepatotoxicity.
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